Clinical trialNCT01703793CompletedPhase 2Interventional

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

SponsorMedicis Global Service CorporationEnrollment240Seborrheic Dermatitis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Ira Lawrence, MD
Medicis Pharmaceutical
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Facility name not stated
Fremont, California, United States
Facility name not stated
Los Angeles, California, United States
Facility name not stated
San Diego, California, United States
Facility name not stated
New Haven, Connecticut, United States
Facility name not stated
Aventura, Florida, United States
Facility name not stated
Augusta, Georgia, United States
Facility name not stated
Snellville, Georgia, United States
Facility name not stated
Evansville, Indiana, United States
Facility name not stated
Detroit, Michigan, United States
Facility name not stated
Fridley, Minnesota, United States
Facility name not stated
Paramus, New Jersey, United States
Facility name not stated
Mount Kisco, New York, United States
Facility name not stated
New York, New York, United States
Facility name not stated
High Point, North Carolina, United States
Facility name not stated
Portland, Oregon, United States
Facility name not stated
Philadelphia, Pennsylvania, United States
Facility name not stated
Arlington, Texas, United States
Facility name not stated
Austin, Texas, United States
Facility name not stated
College Station, Texas, United States
Facility name not stated
Plano, Texas, United States
Facility name not stated
Webster, Texas, United States
Facility name not stated
Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Test Product 10156Test Product 49778Vehicle

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2012
Primary completion: 31 Jan 2013
Completion: 31 Jan 2013
Last update posted: 9 Jan 2013
Registered enrollment: 240
Registry id: NCT01703793

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.